Shareholders' Equity - Restricted Stock (Details) - USD ($)			3 Months Ended		12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Restricted Stock Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock based compensation expense			$ 321,569	$ 165,064
Compensation cost not yet recognized	$ 2,651,858		$ 2,655,308		$ 2,651,858
Weighted average period for recognition			1 year 3 months 29 days		1 year 5 months 1 day
Number outstanding
Balance non-vested Stock at beginning of period (in shares)			491,536	298,210	298,210
Granted (in shares)			63,980		358,546
Vested (in shares)			(10,064)		(165,220)
Balance non-vested Stock at end of period (in shares)	491,536	298,210	545,452		491,536
Weighted Average Remaining Life
Granted (in years)			1 year 10 months 13 days		1 year 10 months 24 days
Balance non-vested Stock at end of period (in years)	1 year 8 months 26 days	1 year 8 months 26 days	1 year 6 months 10 days		1 year 8 months 26 days
Performance Shares
Number outstanding
Vested (in shares)					(15,833)
Board of Directors | Restricted Stock Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average market price at grant date (in dollars per share)			$ 5.08
Number outstanding
Granted (in shares)			63,980
Management, Employees, and Board Of Directors | Restricted Stock Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average market price at grant date (in dollars per share)					$ 5.42
Number outstanding
Granted (in shares)					358,546